|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
6
|
|
pubmed:dateCreated |
2006-6-8
|
|
pubmed:abstractText |
Recent studies have provided increasing evidence that hepatocyte growth factor (HGF) has a pathophysiological role in the development of diabetic complications. We set out to determine the relationship between serum HGF and risk factors for macroangiopathy including carotid atherosclerosis. Carotid atherosclerosis is an established and important risk factor for both cerebral and coronary artery diseases.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Jun
|
|
pubmed:issn |
0742-3071
|
|
pubmed:author |
pubmed-author:HamaguchiTT,
pubmed-author:HasegawaYY,
pubmed-author:IshikawaTT,
pubmed-author:KakishitaEE,
pubmed-author:KatsunoTT,
pubmed-author:KohriKK,
pubmed-author:KonyaHH,
pubmed-author:NütaniKK,
pubmed-author:NambaMM,
pubmed-author:SuehiroAA,
pubmed-author:UmeharaAA
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
23
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
617-22
|
|
pubmed:meshHeading |
pubmed-meshheading:16759302-Age Factors,
pubmed-meshheading:16759302-Aged,
pubmed-meshheading:16759302-Biological Markers,
pubmed-meshheading:16759302-Carotid Arteries,
pubmed-meshheading:16759302-Carotid Artery Diseases,
pubmed-meshheading:16759302-Diabetes Mellitus, Type 2,
pubmed-meshheading:16759302-Female,
pubmed-meshheading:16759302-Hepatocyte Growth Factor,
pubmed-meshheading:16759302-Humans,
pubmed-meshheading:16759302-Hypertension,
pubmed-meshheading:16759302-Linear Models,
pubmed-meshheading:16759302-Male,
pubmed-meshheading:16759302-Middle Aged,
pubmed-meshheading:16759302-Multivariate Analysis,
pubmed-meshheading:16759302-Myocardial Ischemia,
pubmed-meshheading:16759302-Risk Factors,
pubmed-meshheading:16759302-Systole,
pubmed-meshheading:16759302-Tunica Intima,
pubmed-meshheading:16759302-Tunica Media
|
|
pubmed:year |
2006
|
|
pubmed:articleTitle |
Clinical significance of circulating hepatocyte growth factor, a new risk marker of carotid atherosclerosis in patients with Type 2 diabetes.
|
|
pubmed:affiliation |
The Division of Diabetes and Metabolism, Internal Medicine, Hyogo College of Medicine, Nishinomiya, Hyogo, Japan.
|
|
pubmed:publicationType |
Journal Article
|
